Treace Medical Concepts (TMCI) EBT Margin (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly EBT Margin came in at 35.43% in Q2 2026, up 155.0% on a YoY basis from 13.89% in Q2 2025, and up 8.31% quarter-over-quarter from 38.64% in Q1 2026.
Powered by 
Analysis
Treace Medical Concepts (TMCI) EBT Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported EBT Margin for 7 consecutive years, with 35.43% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 155.0% year-over-year to 35.43%; the trailing twelve-month figure through Jun 2026 stood at 27.98% (down 478.0% YoY), and the FY2025 full-year result was 26.66%, up 12.0% from the prior year.
- EBT Margin rose to 35.43% in Q2 2026 per TMCI's latest filing, from 38.64% in the prior quarter.
- Across five years, EBT Margin topped out at 0.9% in Q4 2024 and bottomed at 47.95% in Q2 2024.
- Historically, EBT Margin has averaged 29.89% across 5 years, with a median of 33.37% in 2024.
- The sharpest annual moves came in 2023 and 2024: EBT Margin surged 1306 bps in 2023, then plunged 1848 bps in 2024.
- Over 5 years, EBT Margin stood at 8.15% in 2022, then dropped by 26 bps to 10.25% in 2023, then soared by 91 bps to 0.9% in 2024, then slumped by 1098 bps to 10.79% in 2025, then plunged by 228 bps to 35.43% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 35.43%, 38.64%, and 10.79% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.32% |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn | -35.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.43% |
| Mar 31, 2026 | -38.64% |
| Dec 31, 2025 | -10.79% |
| Sep 30, 2025 | -32.62% |
| Jun 30, 2025 | -36.97% |
| Mar 31, 2025 | -30.53% |
| Dec 31, 2024 | -0.90% |
| Sep 30, 2024 | -34.11% |
| Jun 30, 2024 | -47.95% |
| Mar 31, 2024 | -36.69% |
| Dec 31, 2023 | -10.25% |
| Sep 30, 2023 | -43.04% |
| Jun 30, 2023 | -29.48% |
| Mar 31, 2023 | -32.19% |
| Dec 31, 2022 | -8.15% |
| Sep 30, 2022 | -36.57% |
| Jun 30, 2022 | -42.54% |
| Mar 31, 2022 | -31.12% |
| Dec 31, 2021 | -19.80% |
| Sep 30, 2021 | -29.69% |